AGP Picks
View all

The California STEM Reporter
Provided by AGP

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 18, 2026

Which CRO Is Good at Protein Degradation?
May 18, 2026

Which CRO Is Good at Protein Degradation?

Indeterminate EIN Presswire
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Berto Acquisition Corp. II Announces Closing of Upsized $315,100,000 Initial Public Offering
May 18, 2026

Berto Acquisition Corp. II Announces Closing of Upsized $315,100,000 Initial Public Offering

Indeterminate GlobeNewswire
Inspired Announces CFO Transition
May 18, 2026

Inspired Announces CFO Transition

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
May 18, 2026

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II
May 18, 2026

GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II

Indeterminate GlobeNewswire
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire
AvePoint to Participate in Upcoming Investor Conferences 
May 18, 2026

AvePoint to Participate in Upcoming Investor Conferences 

Indeterminate GlobeNewswire
BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square
May 18, 2026

BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square

Indeterminate GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May 18, 2026

Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May 18, 2026

Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland

Indeterminate GlobeNewswire
Floatboat Introduces FloatIM, Turning Desktop Workspaces Into Agent Networks
May 18, 2026

Floatboat Introduces FloatIM, Turning Desktop Workspaces Into Agent Networks

Indeterminate EIN Presswire
project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion
May 18, 2026

project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion

Indeterminate GlobeNewswire
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  
May 18, 2026

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  

Indeterminate GlobeNewswire
Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT
May 18, 2026

Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.